Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide for Acute Bronchiolitis in Infants
NCT03053388Phase 3Completed
- Sponsor
- Beyond Air
- Start
- Mar 2017
- Primary completion
- Apr 2018
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nitric oxide in bronchiolitis (2 arms), sponsored by Beyond Air. Primary endpoint: Hospital Length of Stay at 12 days. Started Mar 2017; status: completed.
02
Drugs
nitric oxide
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on NCT03053388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03053388.